3rd Quarter - Report

MEHLMAN CONSULTING, INC. for VIZIENT INC

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

340b drug pricing program. Health care workforce. Health care supply chain. Health care drug shortages. H.R. 9599 - SECURE 340B Act - Strengthening the Exercise of Controls and Upgrading Requirements of Efficiency in 340B Act. S. 5244 - SUSTAIN 340B Act - Supporting Underserved and Strengthening Transparency, Accountability, and Integrity Now and for the Future of 340B Act.

LobbyistCovered position, as disclosed
LAUREN ARONSON —
ALYENE MLINAR —
DEAN ROSEN —
CAITLIN VAN SANT —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 5244 (119th), H.R. 9599 (119th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.